BioNTech Should Be Able to Increase Vaccine Output: CEO

The transcript discusses the challenges and strategies in vaccine production and distribution, focusing on partnerships and capacity expansion. It highlights the issues faced in Europe, particularly Germany, and the efforts to meet global vaccine demands. The potential for booster shots and the efficacy of vaccines against new strains are explored. The future of mRNA technology in various fields, including infectious diseases and cancer, is also discussed.

What are the potential future uses of mRNA vaccine technologies beyond COVID-19?

What factors could lead to a need for booster vaccines in the future?

What strategies are being discussed to prepare for potential new variants of the virus?

How do the current vaccine orders reflect the demand for vaccine doses?